RhumbLine Advisers’s iTeos Therapeutics ITOS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
|
|||||
|
2025
Q2 | $487K | Buy |
|
|||||
|
2025
Q1 | $260K | Buy |
|
|||||
|
2024
Q4 | $330K | Buy |
|
|||||
|
2024
Q3 | $426K | Sell |
|
|||||
|
2024
Q2 | $666K | Buy |
|
|||||
|
2024
Q1 | $564K | Buy |
|
|||||
|
2023
Q4 | $440K | Sell |
|
|||||
|
2023
Q3 | $756K | Buy |
|
|||||
|
2023
Q2 | $859K | Buy |
|
|||||
|
2023
Q1 | $834K | Buy |
|
|||||
|
2022
Q4 | $1.14M | Buy |
|
|||||
|
2022
Q3 | $1.07M | Buy |
|
|||||
|
2022
Q2 | $1.04M | Buy |
|
|||||
|
2022
Q1 | $1.4M | Buy |
|
|||||
|
2021
Q4 | $1.27M | Buy |
|
|||||
|
2021
Q3 | $723K | Buy |
|
|||||
|
2021
Q2 | $671K | Buy |
|
|||||
|
2021
Q1 | $635K | Buy |
|
|||||
|
2020
Q4 | $356K | Buy |
|
|||||
|
2020
Q3 | $213K | Buy |
|